References
1. Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J 2019;16:69.
2. Corman VM, Muth D, Niemeyer D, et al. Hosts and sources of endemic human coronaviruses. Adv Virus Res 2018;100:163–88.
3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382:727–33.
4. Gorbalenya AE, Baker SC, Baric RS, et al. Severe acute respiratory syndrome-related coronavirus: the species and its viruses—a statement of the coronavirus study group. bioRxiv 2020. https://doi.org/10.1101/2020.02.07.937862.
5. Lai CC, Shih TP, Ko WC, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 2020;55:105924.
6. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020.
7. Singhal T. A review of coronavirus disease-2019 (COVID-19). Indian J Pediatr 2020;87:281–6.
8. Ling Z, Xu X, Gan Q, et al. Asymptomatic SARS-CoV-2 infected patients with persistent negative CT findings. Eur J Radiol 2020;126:108956.
9. Kaiser J. How sick will the coronavirus make you? The answer may be in your genes. Science. https://www.Sciencemag.Org/news/2020/03/how-sick-will-coronavirus-make-you-answer-may-be-your-genes; 2020 [accessed 17 April 2020]. Ref Type: Internet Communication.
10. Instituto de Diagnóstico y Referencia Epidemiológicos. Lineamientos para la vigilancia por laboratorio de la influenza y otros virus respiratorios, InDRE. México: Secretaría de Salud; 2017 [accessed 17 April 2020] Ref Type: Internet Communication.
11. Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019- nCoV) by real-time RT-PCR. Euro Surveill 2020;25:2000045.
12. Dirección General de Epidemiología. Anuario de morbilidad 2015–2018. http://www.Epidemiologia.Salud.Gob.Mx/doctos/infoepid/publicaciones/2011/anuarios/p_epi_y_estad_de_la_mortalidad_mexico_2008.Pdf; 2020 [accessed 21 April 2020]. Ref Type: Internet Communication.
13. Troeger C, Blacker B, Khalil IA, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis 2018;18:1191–210.
14. Fernandes-Matano L, Monroy-Munoz IE, Angeles-Martinez J, et al. Prevalence of non-influenza respiratory viruses in acute respiratory infection cases in Mexico. PLoS One 2017;12:e0176298.
15. Fernandes-Matano L, Monroy-Munoz IE, Bermudez de Leon M, et al. Analysis of influenza data generated by four epidemiological surveillance laboratories in Mexico, 2010-2016. Epidemiol Infect 2019;147:e183.
16. Navarro-Mari JM, Perez-Ruiz M, Galan Montemayor JCG, et al. Circulation of other respiratory viruses and viral co-infection during the 2009 pandemic influenza. Enferm Infecc Microbiol Clin 2012;30 Suppl 4:25–31.
17. Pinky L, Dobrovolny HM. Coinfections of the respiratory tract: viral competition for resources. PLoS One 2016;11:e0155589.
18. Dobrescu I, Levast B, Lai K, et al. In vitro and ex vivo analyses of co-infections with swine influenza and porcine reproductive and respiratory syndrome viruses. Vet Microbiol 2014;169:18–32.
19. Lin L, Verslype C, van Pelt JF, et al. Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses. Eur J Gastroenterol Hepatol 2006;18:1311–9.
20. Wiegand SB, Jaroszewicz J, Potthoff A, et al. Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-gamma-induced protein 10 levels in HBV/HCV-coinfected patients. Clin Microbiol Infect 2015;21:710.e1–9.